medigraphic.com

2019, Número 3

<< Anterior

Rev Educ Bioquimica 2019; 38 (3)


The HIV epidemic is not over

Cabañas N

Idioma: Español
Referencias bibliográficas: 9
Paginas: 86-87
Archivo PDF: 77.94 Kb.


FRAGMENTO

In recent days I read some papers about HIV and by coincidence and causality I heard at least five more times about HIV as a matter of conversation. In another occasion, my peers and I were discussing random subjects, and someone asked about clinical laboratory procedures, and for some reason we finished discussing about HIV. The particular question was, is there any treatment for people that has contact with a needle used in an HIV patient? My rapid answer was not, but someone else exclaimed “I do not believe you”.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Becerra, J. C., Bildstein, L. S., & Gach, J. S. (2016). Recent Insights into the HIV/ AIDS Pandemic. Microb Cell, 3(9), 451-475. doi:10.15698/mic2016.09.529

  2. Beekmann, S. E., & Henderson, D. K. (2014). Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers). Infect Dis Clin North Am, 28(4), 601-613. doi:10.1016/j.idc.2014.08.005

  3. Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., . . . Team, H. S. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med, 365(6), 493-505. doi:10.1056/NEJMoa1105243

  4. Diprose, P., Deakin, C. D., & Smedley, J. (2000). Ignorance of post-exposure prophylaxis guidelines following HIV needlestick injury may increase the risk of seroconversion. Br J Anaesth, 84(6), 767-770. doi:10.1093/oxfordjournals. bja.a013591

  5. Gupta, R. K., Abdul-Jawad, S., McCoy, L. E., Mok, H. P., Peppa, D., Salgado, M., . . . Olavarria, E. (2019). HIV-1 remission following CCR5Delta32/ Delta32 haematopoietic stem-cell transplantation. Nature, 568(7751), 244-248. doi:10.1038/ s41586-019-1027-4

  6. Jain, S., Oldenburg, C. E., Mimiaga, M. J., & Mayer, K. H. (2015). Subsequent HIV infection among men who have sex with men who used non-occupational post-exposure prophylaxis at a Boston community health center: 1997- 2013. AIDS Patient Care STDS, 29(1), 20-25. doi:10.1089/apc.2014.0154

  7. Krakower, D. S., Jain, S., & Mayer, K. H. (2015). Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis. Curr HIV/AIDS Rep, 12(1), 127-138. doi:10.1007/s11904-014-0253-5

  8. Kurth, A. E., Celum, C., Baeten, J. M., Vermund, S. H., & Wasserheit, J. N. (2011). Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep, 8(1), 62-72. doi:10.1007/s11904-010-0063-3

  9. Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., Degen, O., . . . Group, P. S. (2019). Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIVpositive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. doi:10.1016/S0140-6736(19)30418-0




2020     |     www.medigraphic.com